Work

Association between Serum Vitamin D levels and the Atherogenic index of plasma, among patients with Type II Diabetes Mellitus, A Cross Sectional Study

Year: 2026
Type: article
Study design: Observational Study
Abstract: Introduction: The Vitamin D deficiency and insufficiency is a wide spread global health issue, highly prevalent, regardless of age, gender, and country of origin. Vitamin D is known to regulate insulin secretion and synthesis by beta cells of pancreas, thus deficiency contributes to development of Diabetes Mellitus. Apart from glycaemic control, vitamin D is also involved in lipid metabolism. The low levels of vitamin D, enables vascular inflammation, endothelial dysfunction, foam cell formation and smooth muscle proliferation. Increasing circulating vitamin D levels, has been found to reduce the risk of hypertension, stroke, and myocardial infarction effectively. Dyslipidaemia, an important public health problem, is an independent risk factor for cardiovascular disease. The vitamin D has an inverse association with LDL cholesterol, contributing to the development of dyslipidaemia in deficiency. AIM: To evaluate the association between serum vitamin D levels and the Atherogenic index of plasma (AIP), among patients with Type II Diabetes Mellitus. Materials and methods: This analytical cross-sectional study was conducted in the Department of Biochemistry, Mamata Academy of Medical Sciences, Bachupally, Hyderabad, Telangana, from January 2026 to June 2026. A total of 152 subjects were included in the study, comprising 76 individuals with Type 2 Diabetes Mellitus (T2DM) and 76 healthy controls. Glycemic control was assessed by measuring glycosylated hemoglobin (HbA1c) by high performance liquid chromatography (HPLC), while serum vitamin D levels were estimated using the chemiluminescent immunoassay (CLIA) method. Dyslipidaemia indices were calculated from lipid profile parameters, including total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and verylow-density lipoprotein cholesterol (VLDL-C). Statistical analyses were performed using RStudio version 4.5.1 (202506-13 ucrt). The differences in HbA1c, serum vitamin D levels, and dyslipidaemia indices between the study groups were assessed using the Mann–Whitney U test. The associations between serum vitamin D, HbA1c, and dyslipidaemia indices were evaluated using Spearman’s rank correlation analysis. Conclusion: Patients with Type 2 Diabetes Mellitus (T2DM) and poor glycaemic control may have an increased atherogenic risk, suggesting that HbA1c may serve as a useful marker for assessing cardiovascular risk in this population. The vitamin D deficiency is associated with poor glycemic control and atherogenic dyslipidemia. Therefore, improving vitamin D status as an important indicator may alleviate AIP as a surrogate marker for predicting the risk of cardiovascular events in healthy population.
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W7235660105
FWCI:
Cites: 24
Cited by:
Related to: 10